Recent 8-K filings for CCRN

• May 07, 2026 23:59 UTC m_and_a materiality 0.85 positive item 1.01item 7.01item 8.01item 9.01

  Cross Country Healthcare to be acquired by Knox Lane for $13.25/share in $437M all-cash deal

  Deal valued at ~$437M, with stockholders receiving $13.25 per share in cash.

• May 07, 2026 23:59 UTC earnings materiality 0.60 negative item 2.02item 7.01item 9.01

  Cross Country Healthcare Q1 2026 revenue down 18% YoY, net loss widens to $4.3M

  Revenue $241.1M, down 18% YoY; gross profit margin 19.7%, down 30 bps.

• Mar 04, 2026 23:59 UTC earnings materiality 0.90 negative item 2.02item 7.01item 9.01

  Cross Country Healthcare Q4 2025 revenue down 24% YoY; net loss of $82.9M

  Revenue $236.8M in Q4 2025, down 24% YoY; full-year revenue $1.054B, down 22%.

• Dec 15, 2025 23:59 UTC leadership materiality 0.90 neutral item 5.02item 7.01item 9.01

  Cross Country CEO Martins departs; co-founder Clark returns as CEO after Aya deal termination

  CEO John Martins separated effective Dec 14, 2025; receives severance of 2-year base salary ($875K) plus average bonus.

• Dec 04, 2025 23:59 UTC other_material materiality 0.80 negative item 1.02item 7.01item 9.01

  Cross Country Healthcare merger with Aya Healthcare terminated; to receive $20M fee; starts buybacks

  Merger agreement with Aya Healthcare terminated effective Dec 4, 2025 after failing to close by Dec 3, 2025 end date.

• Nov 12, 2025 23:59 UTC earnings materiality 0.65 negative item 2.02item 7.01item 9.01

  Cross Country Healthcare Q3 revenue $250M, down 21% YoY; net loss $4.8M

  Revenue $250.1M, down 21% YoY and 9% sequentially; gross margin 20.4% flat.

• Sep 03, 2025 23:59 UTC m_and_a materiality 0.60 neutral item 8.01

  Cross Country Healthcare extends merger deadline to Dec 3, 2025; FTC compliance certified

  Merger end date automatically extended from Sept 3, 2025 to Dec 3, 2025 per the Merger Agreement.

• Aug 06, 2025 23:59 UTC earnings materiality 0.70 negative item 2.02item 7.01item 9.01

  Cross Country Healthcare Q2 revenue down 19% YoY, net loss of $6.7M, negative adjusted EPS

  Revenue $274.1M, down 19% YoY; gross margin 20.4%, down 40 bps.

• May 07, 2025 23:59 UTC earnings materiality 0.60 negative item 2.02item 7.01item 9.01

  Cross Country Q1 revenue down 23% YoY to $293.4M; adjusted EPS $0.06

  Revenue $293.4M, down 23% YoY; net loss $490K ($0.02 loss per share).

• Mar 05, 2025 23:59 UTC earnings materiality 0.75 negative item 2.02item 7.01item 9.01

  Cross Country Healthcare reports Q4 2024 revenue down 25% YoY, net loss of $3.8M

  Q4 2024 revenue $309.9M, down 25% YoY and 2% sequentially.

• Feb 28, 2025 23:59 UTC m_and_a materiality 0.85 neutral item 5.07item 8.01item 9.01

  Stockholders approve Aya Healthcare acquisition; merger expected H2 2025

  Over 78% of shares voted; 25.66M votes for Merger Agreement, 11K against.

• Feb 21, 2025 23:59 UTC regulatory materiality 0.60 negative item 8.01

  Cross Country Healthcare receives FTC Second Request for Aya merger; close expected H2 2025

  FTC issued Second Request under HSR Act, extending waiting period until 30 days after substantial compliance by both parties.

Earnings & guidance

Materiality & sentiment trend

Max materiality 0.90 · Median 0.60 · Most common event earnings

1 positive 8 negative 13 neutral

source · CCRN on sec.gov